| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-04-19 16:20:42 -0600 |
| HMDB ID |
HMDB00011 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
(R)-3-Hydroxybutyric acid |
| Description |
(R)-3-Hydroxybutyric acid is a butyric acid substituted with a hydroxyl group in the beta or 3 position. 3-hydroxybutyric acid, or beta-hydroxybutyrate, is involved in the synthesis and degradation of ketone bodies. Like the other ketone bodies (acetoacetate and acetone), levels of beta-hydroxybutyrate are raised in the blood and urine in ketosis. Beta-hydroxybutyrate is a typical partial-degradation product of branched-chain amino acids (primarily valine) released from muscle for hepatic and renal gluconeogenesis This acid is metabolized by 3-hydroxybutyrate dehydrogenase (catalyzes the oxidation of D-3-hydroxybutyrate to form acetoacetate, using NAD+ as an electron acceptor). The enzyme functions in nervous tissues and muscles, enabling the use of circulating hydroxybutyrate as a fuel. In the liver mitochondrial matrix, the enzyme can also catalyze the reverse reaction, a step in ketogenesis. 3-Hydroxybutyric acid is a chiral compound having two enantiomers, D-3-hydroxybutyric acid and L-3-hydroxybutyric acid. In humans, beta-hydroxybutyrate is synthesized in the liver from acetyl-CoA, and can be used as an energy source by the brain when blood glucose is low. It can also be used for the synthesis of biodegradable plastics (Wikipedia). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (R)-(-)-b-Hydroxybutyrate
- (R)-(-)-b-Hydroxybutyric acid
- (R)-(-)-beta-Hydroxybutyrate
- (R)-(-)-beta-Hydroxybutyric acid
- (R)-3-Hydroxybutanoate
- (R)-3-Hydroxybutanoic acid
- (R)-3-Hydroxybutyrate
- 3-D-Hydroxybutyrate
- 3-D-Hydroxybutyric acid
- 3-delta-Hydroxybutyrate
- 3-delta-Hydroxybutyric acid
- BHIB
- D-(-)-3-Hydroxybutyrate
- D-3-Hydroxybutyrate
- D-3-Hydroxybutyric acid
- D-beta-Hydroxybutyrate
- delta-(-)-3-Hydroxybutyrate
- delta-3-Hydroxybutyrate
- delta-3-Hydroxybutyric acid
- delta-beta-Hydroxybutyrate
|
| Chemical Formula |
C4H8O3 |
| Average Molecular Weight |
104.1045 |
| Monoisotopic Molecular Weight |
104.047344122 |
| IUPAC Name |
(3R)-3-hydroxybutanoic acid |
| Traditional IUPAC Name |
(-)-3-hydroxybutyric acid |
| CAS Registry Number |
625-72-9 |
| SMILES |
C[C@@H](O)CC(O)=O |
| InChI Identifier |
InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m1/s1 |
| InChI Key |
WHBMMWSBFZVSSR-GSVOUGTGSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Organic Acids and Derivatives |
| Class |
Hydroxy Acids and Derivatives |
| Sub Class |
Beta Hydroxy Acids and Derivatives |
| Other Descriptors |
- 3-hydroxy monocarboxylic acid(ChEBI)
- Aliphatic Acyclic Compounds
- Hydroxy fatty acids(Lipidmaps)
- Organic Compounds
- Straight Chain Fatty Acids
- hydroxy fatty acid(ChEBI)
- hydroxybutyric acid(ChEBI)
- short-chain fatty acid(ChEBI)
- straight-chain saturated fatty acid(ChEBI)
|
| Substituents |
- Carboxylic Acid
- Secondary Alcohol
- Short Chain Hydroxy Acid
|
| Direct Parent |
Beta Hydroxy Acids and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Butanoate metabolism
|
| Application |
Not Available |
| Cellular locations |
- Cytoplasm
- Extracellular
- Mitochondria
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
49 - 50 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
- Cytoplasm
- Extracellular
- Mitochondria
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
Not Available
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
36 +/- 20 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
86 +/- 53 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
38 +/- 31 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
286 (207-365) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
3.4 umol/mmol creatinine |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
48.0 (0.00-200.0) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
3.6 (1.3-6.4) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
1500.0 +/- 100.0 uM |
Children (1-13 year old) |
Both |
Diabetes |
Without diabetic ketoacidosis
|
| Blood |
Detected and Quantified |
|
7700.0 +/- 300.0 uM |
Children (1-13 year old) |
Both |
Diabetes |
With diabetic ketoacidosis
|
| Blood |
Detected and Quantified |
|
1400.0 +/- 100.0 uM |
Adult (>18 years old) |
Both |
Diabetes |
Without diabetic ketoacidosis
|
| Blood |
Detected and Quantified |
|
7700.0 +/- 200.0 uM |
Adult (>18 years old) |
Both |
Diabetes |
With diabetic ketoacidosis
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
430 (359-501) uM |
Adult (>18 years old) |
Both |
Meningitis |
Bacterial
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
6360 (5350-7370) uM |
Adult (>18 years old) |
Both |
Diabetes |
with ketoacidosis
|
| Urine |
Detected and Quantified |
|
224 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Diabetes |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Diabetes mellitus type 2 |
- Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. Epub 2008 Jan 9.
Pubmed: 18184896
- Tasker RC, Lutman D, Peters MJ: Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005 Jul;6(4):405-11.
Pubmed: 15982426
- Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.
Pubmed: 6321058
|
| Meningitis |
- Subramanian A, Gupta A, Saxena S, Gupta A, Kumar R, Nigam A, Kumar R, Mandal SK, Roy R: Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed. 2005 Jun;18(4):213-25.
Pubmed: 15627241
|
|
| Associated OMIM IDs |
- 125853
(Diabetes mellitus type 2)
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB021869 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
83181  |
| KEGG Compound ID |
C01089  |
| BioCyc ID |
CPD-335  |
| BiGG ID |
36784  |
| Wikipedia Link |
Not Available |
| NuGOwiki Link |
HMDB00011  |
| Metagene Link |
HMDB00011  |
| METLIN ID |
Not Available |
| PubChem Compound |
92135  |
| PDB ID |
3HR  |
| ChEBI ID |
17066  |
| References |
| Synthesis Reference |
Le Sann, Christine; Munoz, Dulce M.; Saunders, Natalie; Simpson, Thomas J.; Smith, David I.; Soulas, Florilene; Watts, Paul; Willis, Christine L. Assembly intermediates in polyketide biosynthesis: enantioselective syntheses of b-hydroxycarbonyl compounds |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Pan JW, Rothman TL, Behar KL, Stein DT, Hetherington HP: Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis. J Cereb Blood Flow Metab. 2000 Oct;20(10):1502-7.
Pubmed: 11043913
- Pan JW, Telang FW, Lee JH, de Graaf RA, Rothman DL, Stein DT, Hetherington HP: Measurement of beta-hydroxybutyrate in acute hyperketonemia in human brain. J Neurochem. 2001 Nov;79(3):539-44.
Pubmed: 11701757
- Plecko B, Stoeckler-Ipsiroglu S, Schober E, Harrer G, Mlynarik V, Gruber S, Moser E, Moeslinger D, Silgoner H, Ipsiroglu O: Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy. Pediatr Res. 2002 Aug;52(2):301-6.
Pubmed: 12149510
- Raunio RP, Leivo PV, Kuusinen AM: Bioluminescent assay of D-3-hydroxybutyrate in serum. J Biolumin Chemilumin. 1986 Jun;1(1):11-4.
Pubmed: 3503522
|